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A B S T R A C T
Background
Primary aspiration of food and fluid is commonly seen in children with feeding and swallowing difficulties associated with a range of
diseases and complex medical conditions. Respiratory sequelae and pneumonia are known to be associated with primary aspiration of
ingested material, however causality between primary aspiration of specific food and fluid types and pulmonary effects in children is
yet to be established in controlled trials. The relative pulmonary morbidity of aspiration of ingested food and fluid materials versus
other causes of respiratory disease such as viral and bacterial causes, secondary aspiration of gastrointestinal contents and predisposing
lung conditions such as chronic neonatal lung disease in a developing immune system is also unclear. Current management decisions
for children who aspirate have to optimise oral nutrition and hydration, while reducing the risk of aspiration to preserve pulmonary
integrity. This generally includes restricting aspirated food or fluids and providing texture-modified diets and thickened fluids. Young
children frequently refuse thickened fluids providing a management dilemma for both families and health professionals.
Objectives
Our objective was to evaluate the efficacy of restriction of oral water ingestion on the pulmonary status of children with thin fluid
aspiration demonstrated on a modified barium swallow study.
Search methods
The Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Airways Collaborative Review Group Specialised
Register,MEDLINE,EMBASE andCINAHLdatabaseswere searchedby theCochraneAirwaysGroup.The latest searchwas performed
in January 2011.
Selection criteria
All randomised controlled trials comparing restriction of oral intake of water with unlimited oral water ingestion were eligible to be
included.
Data collection and analysis
Results of searches were reviewed against a pre-determined criteria for inclusion. No eligible trials were identified for a paediatric
population and thus no data were available for analysis. One trial in an adult population was identified and reported.
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Main results
No randomised controlled trials examining the efficacy of restriction of oral intake of water in the management of children with thin
fluid aspiration were found. In a single study in an adult population with stroke, no significant differences were seen between a control
group of oral water restriction and the experimental group of unlimited oral water ingestion on outcomes such as pneumonia, total
oral fluid intake and dehydration.
Authors’ conclusions
There are no trials that have adequately evaluated the pulmonary effects of allowing or restricting oral water ingestion in children known
to have primary aspiration of thin fluids. Thus, there is currently an absence of evidence to support a strict approach of full restriction
of oral intake of water or support a more liberal approach of allowing oral water ingestion in children with primary aspiration of thin
fluids.
P L A I N L A N G U A G E S U M M A R Y
Restriction of oral intake of water for aspiration lung disease in children
Primary aspiration of food and fluid can cause serious lung consequences in infants and children. Treatment recommendations for
children who have primary aspiration of thin fluids includes restriction of thin fluids and provision of thickened fluids. Children often
refuse to drink thickened fluids presenting a challenge for families to ensure that the child takes sufficient fluid. Allowing children who
have thin fluid aspiration to drink water may assist in providing enough fluid without endangering the lung . This review found no
evidence about drinking water in children with primary aspiration of thin fluids.
B A C K G R O U N D
One of the most significant complications of dysphagia or feed-
ing difficulty is aspiration, which is defined as entry of material
into the airway below the level of the true vocal folds (Logemann
1983). Primary aspiration is commonly seen in infants and chil-
drenwith feeding and swallowing problems associated with neuro-
logical disease, anatomical anomalies and other aetiologies (Weiss
1988; Arvedson 1994; Colombo 1999). Short term manifesta-
tions of pulmonary aspiration are cough, wheeze, increased num-
ber and prolonged respiratory infections and atelectasis (Colombo
1999; Loughlin 1994). Cough is a common symptom of the above
conditions. Long term consequences of pulmonary aspiration in-
clude bronchiectasis, bronchiolitis obliterans and follicular bron-
chiolitis, respiratory distress, airway obstruction, acute or recur-
rent pneumonia, frequent or long-lasting upper respiratory infec-
tions and chronic lung disease (Loughlin 1989; Loughlin 1994;
Arvedson 1998; Colombo 1999). Weiss suggested that although
aspiration is an important complication in a patient of any age,
it may assume particular importance in the developing infant or
child with dysphagia (Weiss 1988). He proposed that infants and
children may lack some of the compensatory mechanisms that
enable adults to protect the airway, thus making early detection
and prevention of aspiration essential in order to avoid severe and
possibly irreversible pulmonary morbidity.
Dysphagia may also cause other complications such as failure
to maintain an adequate nutritional intake and hydration. A
Cochrane review of treatment for dysphagia in chronic muscle
disease investigated the effect of various interventions on a pri-
mary outcome of nutritional issues including stabilisation of pre-
viously documented weight loss (Hill 2004). The reviewers found
no RCTs and concluded that “It is therefore not possible to decide
on the most appropriate treatment for a given individual based on
current evidence”. Our review focuses primarily on aspiration and
respiratory outcomes.
Currently, there is no gold standard outcome measure for the as-
sessment of primary aspiration. A range of instrumental proce-
dures are available to evaluate the occurrence of primary aspiration.
These techniques include the fibreoptic endoscopic evaluation
of swallowing (FEES), radionuclide salivagram, nuclear scintigra-
phy, bronchoscopy and use of the lipid laden macrophage index,
static radiographs, upper gastrointestinal studies and the modi-
fied barium swallow study (MBS) (Sonies 1991; Bar-Sever 1995;
Leder 1998; Bauer 1999; Hartnick 2000; Leder 2000; Ding 2002;
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Tohara 2003). Inflammatory changes consistent with neutrophilic
inflammation and lipid laden macrophage index are sometimes
used as supportive markers of aspiration, but neither marker is
specific for aspiration (Bauer 1999; Ding 2002). However, the
modified barium swallow study (MBS) is currently the most fre-
quently used tool to detect primary aspiration during feeding in
paediatrics (Sonies 1991; O’Donoghue 1999; Miller 2003).
Current practice following detection of aspiration on any consis-
tency during an MBS is to implement swallowing strategies or in-
direct intervention techniques such as alterations in postural vari-
ations and food characteristics such as temperature, viscosity, and
texture (Newman 2000; Arvedson 1997;Seddon 2003). Fluid con-
sistencies are themost commonly aspiratedmaterial in people with
swallowing dysfunction (Arvedson 1994; Rogers 1994; Taniguchi
1994; Morton 1999; Friedman 2000; Lefton-Greif 2000). In the
case of thin fluids, texture restriction may entail eliminating the
thin fluids from a person’s diet and allowing thickened fluids to be
orally consumed (Logemann 1983; Newman 2000). Alternative
methods of nutrition such as nasogastric or gastrostomy tubes may
be necessary to provide hydrationneeds (Arvedson 1997;Newman
2000). While existing evidence suggests a strong association be-
tween aspiration of thick fluid and solid textures with pneumonia
(Taniguchi 1994), little evidence exists to prove or disprove a re-
lationship between aspiration of thin liquids, and particularly wa-
ter, with the development of pneumonia (Taniguchi 1994; Garon
1997). The pathophysiology resulting from aspiration depends
on several factors including the presence of particulate matter, a
relatively low pH (<2.5), bacterial contamination from the oral
or gastrointestinal tracts and volume of gastric aspirate (> 0.3 ml
per kilogram of body weight (20-25 ml in adults) (Nahum 1981;
Kirsch 1988). Water has a neutral pH of approximately 7, with
Australian drinkingwater requirements recommending a pHvalue
between 6.5 - 8.5 (NHMRC 1996). Small amounts of aspiration
of this liquid with a relatively neutral pH should have little pul-
monary or health effects if the current literature is to be believed.
In current medical practice, some children who are known to as-
pirate on thin fluids have full restriction of thin fluids orally, while
others are allowed to ingest water orally. There is no research at
present that systematically investigates the health effects of water
ingestion in children who are know to aspirate thin fluids. Garon
and colleagues investigated the development of pneumonia in two
groups of adult stroke patients with thin fluid aspiration docu-
mented onMBS (Garon 1997). They found that patients allowed
unlimited water ingestion did not have increased pulmonary com-
plications compared to those on thickened fluids and full thin
fluid restriction (Garon 1997). Furthermore, the group allowed
unrestricted water ingestion reported higher satisfaction rates on
quality of life measures (Garon 1997). The results of studies by
Garon and colleagues andTaniguchi andMoyer have thrown open
the debate on the relative effects of ingesting water and possible
aspiration on the health and well-being of young children (Garon
1997; Taniguchi 1994). Relative benefits to the quality of life of
swallowing impaired children and their families and associated
health benefits in providing adequate hydration and negating the
need for tubes may far outweigh the relative risks of the primary
aspiration itself. Hence, there is a need for systematic evaluation of
the effects of water ingestion in children who aspirate thin fluids
in terms of pulmonary health and quality of life.
O B J E C T I V E S
To evaluate the efficacy of restriction of oral water ingestion on
pulmonary status of children with aspiration demonstrated on a
modified barium swallow.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials of water restriction in children
with documented aspiration on fluids would be included in the
review.
Types of participants
Participants included children aged < 14 years whose modified
barium swallow had shown aspiration of thin fluids. There were
no exclusion criteria.
Types of interventions
Interventions included all randomised controlled comparisons of
oral water restriction. Trials that included the use of other medi-
cations or interventions were to be included if all participants had
equal access to such medications or interventions.
Types of outcome measures
It was planned to obtain data on at least one of the following
outcome measures:
Primary outcome:
a) proportions of participants who were not cured or not substan-
tially improved at follow up (clinical failure).
Secondary outcomes:
b) proportions of participants who were not cured at follow up,
c) proportions of participantswhowere not substantially improved
at follow up,
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d) mean difference in the number of respiratory episodes (defined
by diary cards or acute respiratory illness score)
e) proportions requiring hospitalization for respiratory illness
f ) mean difference in symptoms and signs (mean improvement in
clinical state)
g) proportions developing new respiratory complications such
as bronchiectasis, bronchiolitis obliterans, follicular bronchiolitis
etc,
h) proportions experiencing adverse effects of the intervention
(e.g.. dehydration, gastrostomy button complications etc),
i) proportions requiring new intervention for management of as-
piration e.g.. requirement for gastrostomy, diversion surgery, etc.
The proportions of participants who failed to improve on treat-
ment and themean clinical improvementwere to be determinedby
using the following hierarchy of assessment measures (i.e.. where
two or more assessment measures were reported in the same study,
the outcome measure that was listed first in the hierarchy was to
be used).
i) Objective measurements of cough indices (cough frequency).
ii) Symptomatic (Quality of life, Likert scale, visual analogue scale,
level of interference of respiratory symptoms such as cough, cough
diary) - assessed by child
iii) Symptomatic (Quality of life, Likert scale, visual analogue scale,
level of interference of respiratory symptoms such as cough, cough
diary) - assessed by the parents/carers.
iv) Symptomatic (Likert scale, visual analogue scale, level of in-
terference of respiratory symptoms such as cough, cough diary) -
assessed by clinicians.
v) Radiological assessment of chest (High resolution computed
tomography and chest Xray)
vi) Relevant airway markers consistent with neutrophilic inflam-
mation or surrogate markers of aspiration such as lipid laden
macrophage index.
Search methods for identification of studies
The following topic search strategy was used to identify relevant
randomised controlled trials from the listed electronic databases:
(“aspiration” OR “aspirate” OR “silent aspiration” OR “dyspha-
gia” OR “feeding difficulties” OR “swallowing difficulties” OR
“swallow abnormalities” OR “swallow dysfunction” OR “degluti-
tion” OR “deglutition disorders” OR “oropharyngeal” OR “bar-
ium meal” OR “swallow evaluation” OR “videofluoroscopy” OR
“modified barium swallow”, all as (textword) or (MeSH) )
AND
(“water” or “fluid” or “liquid” or “drink”; all as (textword) or
(MeSH))
AND
(“child” OR “children” OR “infant” as (textword) or (MeSH))
For the full searches see Appendix 1.
Trials were identified from the following sources:
1. The Cochrane Controlled Trials Register (CENTRAL)
which includes the Airways Collaborative Review Group
Specialised Trials Register.
2. MEDLINE (1966-present). Topic search strategy
combined with the Medline randomised controlled trial search
filter as outlined in the Airways Group module.
3. OLDMEDLINE (1951-1965). Topic search strategy
combined with the Medline randomised controlled trial search
filter as outlined in the Airways Group module.
4. EMBASE (1980-present). Topic search strategy combined
with the Embase randomised controlled trial search filter as
outlined in the Airways Group module.
5. CINAHL (R) (1982-present).
6. The list of references in relevant publications.
7. Written communication with the authors of trials was
included in the review when necessary.
Data collection and analysis
Retrieval of studies
Two reviewers (KW,AC) independently reviewed the title, abstract
and descriptions of studies retrieved in the literature searches to
identify potentially relevant trials for full review. Searches of bibli-
ographies and texts were conducted to identify additional studies.
The same two reviewers independently selected trials for inclusion
from the full text using specific criteria. Agreement was to be mea-
sured using Kappa statistics. Disagreement was to be resolved by
consensus or third party adjudication (SM).
Assessment of Quality
Studies included in the review were to undergo quality assessment
performed independently by all reviewers. Four components of
quality would have been assessed:
1. Allocation concealment. Trials will be scored as: Grade A:
Adequate concealment, Grade B: Unclear, Grade C: Clearly
inadequate concealment (Grade A = high quality).
2. Blinding. Trials will be scored as: Grade A: Participant and
care provider and outcome assessor blinded, Grade B: Outcome
assessor blinded, Grade C: Unclear, Grade D: No blinding of
outcome assessor (Grade A, B = high quality).
3. Reporting of participants by allocation group. Trials will be
scored as: Grade A: The progress of all randomised children in
each group described, Grade B: Unclear or no mention of
withdrawals or dropouts, Grade C: The progress of all
randomised children in each group clearly not described (Grade
A = high quality).
4. Follow-up. Trials will be scored as: Grade A: Outcomes
measured in >90% (where withdrawals due to complications and
side-effects are categorised as treatment failures), Grade B:
Outcomes measured in 80 to 90%, Grade C: Unclear, Grade D:
Outcomes measured in <80% (Grade A = high quality).
While only the allocation concealment quality would have been
displayed in the meta-analysis figures, all assessments would have
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been included in the “Characteristics of included studies” table. In-
ter-reviewer reliability for the identification of high quality studies
for each component were to be measured using the Kappa statistic.
Each study would have been assessed using a one to five scale
described by Jadad (Jadad 1996) and summarised as follows:
Was the study described as randomised? (1= yes; 0 = no)
Was the study described as double blind? (1= yes; 0 = no)
Was there a description of withdrawals and dropouts? (1= yes; 0 =
no)
Was the method of randomisation clearly described and appropri-
ate? (1= yes; 0 = no)
Was the method of double blinding well described and appropri-
ate? (1= yes; 0 = no)
Data Extraction
Trials that satisfied the inclusion criteria were to be reviewed and
the following information recorded: study setting, year of study,
source of funding, patient recruitment details (including number
of eligible children), inclusion and exclusion criteria, randomisa-
tion and allocation concealment method, numbers of participants
randomised, blinding (masking) of participants, care providers and
outcome assessors, intervention (duration and quantification of
water restriction), control (types and methods of dietary manip-
ulation), co-morbidities (all medical problems with particular at-
tention to neurological problems and genetic syndromes), existing
respiratory problems (asthma, bronchiectasis, cystic fibrosis), co-
interventions, numbers of patients not followed up, reasons for
withdrawals from study protocol (clinical, side-effects, refusal and
other), details on side-effects of therapy, and whether intention-
to-treat analyses were possible. Data would have been extracted
on the outcomes described previously. Further information was to
be requested from the authors where required.
Data Analysis
For the dichotomous outcome variables of each individual study,
relative and absolute risk reductions were to be calculated using
a modified intention-to-treat analysis. This analysis assumes that
children not available for outcome assessment have not improved
(and probably represents a conservative estimate of effect). An ini-
tial qualitative comparison of all the individually analysed studies
was to have examined whether pooling of results (meta-analysis)
is reasonable. This takes into account differences in study popula-
tions, inclusion/exclusion criteria, interventions, outcome assess-
ment and estimated effect size.
The results from studies that met the inclusion criteria and re-
ported any of the outcomes of interest would have been included
in the subsequent meta-analysis. The summary weighted risk ratio
and95%confidence interval (fixed effectsmodel)would have been
calculated using the inverse of the variance of each study result for
weighting (Cochrane statistical package, RevMan 4.2). Numbers
needed to treat (NNT) were to be calculated from the pooled OR
and its 95% CI applied to a specified baseline risk using an on-
line calculator (Visual Rx at www.nntonline.net). This calculator
converts the risk in the placebo group to the corresponding odds,
applies the OR to estimate the odds in the treated group, and con-
verts that odds to the corresponding risk and calculates the risk
difference, the inverse of which is the NNT. The outcome indices
would have been assumed to be normally distributed continuous
variables so the mean difference in outcomes could have been es-
timated (weighted mean difference). If studies reported outcomes
using different measurement scales, the standardised mean differ-
ence would have been estimated. In cross-over trials, if data was
combined with parallel studies only data from the first arm would
have been used (Elbourne 2002). In addition, for pooled cross-
over studies, mean treatment differences would have been calcu-
lated from raw data, extracted or imputed and entered as fixed
effects generic inverse variance (GIV) outcome to give weighted
SD unit difference and 95% confidence intervals (RevMan 4.2).
Heterogeneity between the study results would have been tested
to see if it reached statistical significance using a chi-squared test.
The 95% confidence interval estimated using a random effects
model would have been included whenever there were concerns
about statistical heterogeneity.
SUBGROUP ANALYSIS:
An a priori subgroup analysis was planned for
1. Age: infants (<12 months) or children (aged 1-14 years)
2. Complete versus partial water restriction
3. Presence of established lung disease (such as cystic fibrosis,
bronchiectasis, immunodeficiency, chronic neonatal lung disease,
asthma) and gastro-esophogeal reflux disease
4. Medical comorbidity (primary neurological problem versus
others)
5. Method of primary nutrition intake (oral or non-oral: i.e.
nasogastric tube, gastrostomy)
Sensitivity analyses was planned to assess the impact of the poten-
tially important factors on the overall outcomes:
a) study quality;
b) study size;
c) variation in the inclusion criteria;
d) differences in other medications used in the intervention and
comparison groups;
e) differences in outcome measures;
f ) analysis using random effects model;
g) analysis by ’treatment received’;
h) analysis by ’intention-to-treat’; and
i) analysis by study design-parallel and cross over studies.
R E S U L T S
Description of studies
See: Characteristics of excluded studies.
The original searches in 2005 identified 3 potential studies but
none fulfilled the study eligibility criteria. Subsequent searches to
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date (January 2011) revealed no relevant studies. The 2011 search
identified 182 references. See Appendix 2 for the search history.
Risk of bias in included studies
Not applicable.
Effects of interventions
The initial Airways Group Specialised Register/search identified
1364potentially relevant titles. After assessing the abstracts, 3 stud-
ies were considered for inclusion into review but none fulfilled the
study eligibility criteria. Non controlled studies are summarised in
the excluded table. A single RCT was identified in an adult popu-
lation (Garon 1997) who had sustained their first stroke, had good
cognitive skills and could follow a rinsing protocol. This study
found no difference in the occurrence of pneumonia, dehydration
or total fluid intake between a group of adult patients who were
allowed unlimited ingestion of oral water and a group on full re-
striction of thin fluids.
D I S C U S S I O N
No randomised controlled trials on the effects of restriction or al-
lowing orally ingested water in persons with known primary aspi-
ration of fluids in a paediatric population were found. The adult
study on stroke patients suggested that free ingestion of water did
not increase pneumonia events (Garon 1997). However these re-
sults should not be extrapolated to a paediatric population for
several reasons. An adult population with stroke is very different
from infants and young children who may have either acquired
or congenital aetiologies and may have multiple body systems af-
fected. The effects of dysphagia in children are often chronic due
to the complexities of developing (maturing) oral-motor compe-
tence and feeding milestones using impaired body systems, which
may include neurodevelopmental, structural, gastrointestinal and
respiratory compromise, in the context of maturing cognition and
behaviour in children.
Primary aspiration of food and fluid textures is commonly seen in
children with feeding and swallowing difficulties associated with
a range of diseases and complex medical conditions. Respiratory
sequelae and pneumonia are known to be associated with primary
aspiration of ingested material. However causality between pri-
mary aspiration of specific food and fluid textures and pulmonary
effects in children is yet to be established in controlled trials. Cass
and colleagues comment that determination of an intervention
for children with suspected primary aspiration of food or fluids
requires a three step approach that includes establishing whether
aspiration is occurring, quantifying that aspiration and predicting
the long term impact on lung function (Cass 2005). Restriction
of oral ingestion of aspirated food and fluid textures and, in the
case of fluids, prescribing thickened fluids, are commonly recom-
mended when treating children with feeding and swallowing dif-
ficulties (Alper 1996, Logemann 1983). Indeed, current standard
practice in most centres for children with MBS documented evi-
dence of fluid aspiration includes the total restriction of all fluids
including water. This review has found an absence of evidence for
total restriction of water, an intervention that significantly impacts
on amount of extra work on carers (thickening all fluids including
water) as well as hydration status of the child.
While recurrent primary aspiration of food and fluid textures is
commonly believed to lead to “serious and sometimes irreversible
pulmonary damage” in infants and young children (Weiss 1988),
there is no good data on the direct relationship between severity of
aspiration and lung disease. Nevertheless, it is often assumed that
a linear relationship exists between the severity of oropharyngeal
aspiration and the development respiratory compromise or dis-
ease (Cass 2005; Seddon 2003). Taniguchi and Moyer described
(using a case control study) that abnormal MBS is a risk factor for
pneumonia in children (Taniguchi 1994).However, some children
with clinically similar degrees of oropharyngeal aspiration can have
quite different pulmonary responses with some children showing
no apparent effects while others experience severe acute or chronic
complications (Cass 2005). Also, defining pneumonia caused by
aspiration is difficult to prove or disapprove, especially in the con-
text of a child with chronic CXR changes and the known increased
frequency of respiratory infections in children compared to adults
(Leder 2003). The increased frequency of respiratory infections
is likely related to the relative immaturity of the respiratory and
immunological systems of infants and young children. Presence or
co-existence of non aspiration related respiratory infections may
either mask or alter respiratory responses to primary aspiration of
water or other food or fluid substances in this age group. Thus the
relative pulmonary morbidity of aspiration of ingested food and
fluid materials versus other causes of respiratory disease such as
viral and bacterial causes, secondary aspiration of gastrointestinal
contents and predisposing lung conditions such as chronic neona-
tal lung disease in a developing immune system is unclear and
needs to be considered in cohort and controlled studies.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Given the lack of evidence, it is not possible to either recommend
total restriction or liberalisation of oral water ingestion to ’protect’
the pulmonary status of childrenwith thin fluid aspiration demon-
strated on a modified barium swallow study. Clinicians should be
cognisant that water (with a neutral pH) significantly differs from
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other fluids and this review did not examine the effect of non-
water fluids.
Implications for research
Randomised controlled trials to determine the effects of restricting
or allowing oral intake of water in children with thin fluid aspi-
ration are needed to provide evidence-based guidelines for treat-
ing children with oropharyngeal aspiration. The trial(s) should in-
clude data on the relative impact of type and severity of oropharyn-
geal aspiration on the development of aspiration lung disease and
respiratory morbidity. Data on likely confounders and other clini-
cally useful outcomes should also be collected. These include mo-
bility, nutritional status, oral hygiene, co-morbidities (e.g. gastroe-
sophageal reflux, neurological impairment and structural anoma-
lies) and exposure to community-based respiratory disease. Such
data would provide valuable information on the relative impact of
oropharyngeal aspiration in the context of other determinants of
respiratory disease in children.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Garon 1997 Randomised controlled trial in an adult stroke population.
Sheikh 2001 No control group. No intervention trial was included.
Taniguchi 1994 A case-control study design. No intervention trial was included
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D A T A A N D A N A L Y S E S
This review has no analyses.
WH A T ’ S N E W
Last assessed as up-to-date: 27 January 2011.
Date Event Description
28 January 2011 New search has been performed Literature search run. No new included studies identified.
H I S T O R Y
Protocol first published: Issue 2, 2005
Review first published: Issue 4, 2005
Date Event Description
9 September 2008 Amended Converted to new review format.
29 January 2008 New search has been performed Literature search run; no new studies identified
1 August 2005 New citation required and conclusions have changed Substantive amendment
C O N T R I B U T I O N S O F A U T H O R S
KW and AC wrote the primary protocol based on previous protocols involving cough as an outcome measure. For the review, KW and
AC extracted suitable abstracts on the search conducted by Liz Arnold of the Cochrane Airways Group. Analysis and data extraction
was primarily performed by KW with guidance by AC and SM. All authors contributed to writing the review.
D E C L A R A T I O N S O F I N T E R E S T
The authors are currently involved in a RCT examining the effect of restricted vs liberalisation of oral water on the pulmonary status
of children with dysphagia.
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